positions available now

Category Archives: Life Sciences Industry

Relating to the Life Sciences Industry in general

Life Saving Drugs Program: new lease on life, or on life support?

Last week saw the release of the final report of the post-market review into the Life Saving Drugs Program (LSDP), including a response to the report released by the Australian Government. The Life Saving Drugs Program currently provides subsidised access … Continue reading

Posted in Life Sciences Industry, Market Insight, PBS | Tagged , , , | Comments Off on Life Saving Drugs Program: new lease on life, or on life support?

What is Happening with the Provisional Approval Pathway?

We’ve come a long way When the independent review of medicines and medical devices regulation was announced in October 2014, the pharmaceutical sector immediately saw the opportunity for an expediated approval pathway for certain prescription medicines. A provisional approval pathway would allow … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , | Comments Off on What is Happening with the Provisional Approval Pathway?

What is food for special medical purposes (FSMP)?

With a greater recognition of the importance of nutritional support in medical therapy and improved technology, the “food for special medical purposes” (FSMP) market is currently surging. However, many questions arise, what is food for special medical purposes? Where can … Continue reading

Posted in Life Sciences Industry, Medical Services, TGA | Tagged , , , | Comments Off on What is food for special medical purposes (FSMP)?

Stressed? Well your products should be!

Treating your drug substance or drug product with an acid, a base, an oxidising substance, heat or exposing it to direct light might sound extreme, but that is exactly what the TGA want to see in your registration dossier. Assay … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , | Comments Off on Stressed? Well your products should be!

Proposed updates to GVP Module VI and what this might mean for our clients

Good pharmacovigilance practices (GVP) are a set of measures drawn up to facilitate the performance of pharmacovigilance in the European Union (EU). GVP apply to marketing-authorisation holders, the European Medicines Agency and medicines regulatory authorities in EU Member States. The … Continue reading

Posted in Life Sciences Industry, Pharmacovigilance, TGA | Tagged , , , | Comments Off on Proposed updates to GVP Module VI and what this might mean for our clients

Medicine labels: TGO 91 and TGO 92. What’s the impact?

Following years of consultation and review the TGA has issued two new labelling orders to replace the current Therapeutic Good Order No. 69 for specific medicine labelling requirements: Therapeutic Goods Order No. 91 – Standard for labels of prescription and … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , | Comments Off on Medicine labels: TGO 91 and TGO 92. What’s the impact?

Patient support program – the key driver of better health outcomes

Pharmaceutical companies play a key role in supporting the quality use of medicines through patient focused programs. These programs are designed to aid compliance and lifestyle choices. They provide significant value to patients through the accessibility of information and support. … Continue reading

Posted in Life Sciences Industry, Medical Services | Tagged , , | Comments Off on Patient support program – the key driver of better health outcomes

Commercial Eyes Recruiting: Senior Market Access Consultant

Commercial Eyes has a great opportunity for a Senior Market Access consultant to join our dynamic Market Access team. Reporting to the Health Economics and Market Access Manager, this senior consulting role offers the successful candidate the opportunity to gain … Continue reading

Posted in Commercial Eyes, Life Sciences Industry, Market Access | Tagged , , | Comments Off on Commercial Eyes Recruiting: Senior Market Access Consultant

Warning: This medical device literature review may contain traces of LBS

With the release of new clinical evidence guidelines for medical devices, sponsors and manufacturers will be expecting some further guidance on the structure, content and quality of their clinical evaluation reports (CERs). Once final, this guidance will be used in … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , | Comments Off on Warning: This medical device literature review may contain traces of LBS

Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market

As we weave our way through life, we plan…plan our career, plan our finances, plan a holiday and most of us would have at least once in our lifetime planned a party. The key to a successful plan is finding … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, Regulatory Services, TGA | Tagged , | Comments Off on Ready? Get Set…Go! Planning the most appropriate strategy for your product to enter the Australian market
Copyright © 2014 Commercial Eyes